Business Description
Algorae Pharmaceuticals Ltd
ISIN : US53838R1077
Share Class Description:
LVCLY: ADRCompare
Compare
Traded in other countries / regions
1AI.AustraliaLHI0.GermanyLVCLF.USA IPO Date
2010-07-27Description
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for under met medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. The products of the company comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer's disease, NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.94 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26.3 | |||||
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year FCF Growth Rate | 41.5 | |||||
| 3-Year Book Growth Rate | -26.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.53 | |||||
| 9-Day RSI | 7.35 | |||||
| 14-Day RSI | 19.56 | |||||
| 6-1 Month Momentum % | 0.64 | |||||
| 12-1 Month Momentum % | -27.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.94 | |||||
| Quick Ratio | 17.94 | |||||
| Cash Ratio | 4.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.1 | |||||
| Shareholder Yield % | -4.17 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -60.46 | |||||
| ROA % | -56.29 | |||||
| ROIC % | -286.96 | |||||
| 3-Year ROIIC % | -39.15 | |||||
| ROC (Joel Greenblatt) % | -304.01 | |||||
| ROCE % | -63.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4 | |||||
| EV-to-EBIT | -5.77 | |||||
| EV-to-EBITDA | -5.77 | |||||
| EV-to-FCF | -8.33 | |||||
| Earnings Yield (Greenblatt) % | -17.33 | |||||
| FCF Yield % | -11.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LVCLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Algorae Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.006 | ||
| Beta | 0 | ||
| Volatility % | 108.18 | ||
| 14-Day RSI | 19.56 | ||
| 14-Day ATR ($) | 0.001515 | ||
| 20-Day SMA ($) | 0.04392 | ||
| 12-1 Month Momentum % | -27.23 | ||
| 52-Week Range ($) | 0.021 - 0.0835 | ||
| Shares Outstanding (Mil) | 168.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Algorae Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Algorae Pharmaceuticals Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Algorae Pharmaceuticals Ltd Frequently Asked Questions
What is Algorae Pharmaceuticals Ltd(LVCLY)'s stock price today?
The current price of LVCLY is $0.03. The 52 week high of LVCLY is $0.08 and 52 week low is $0.02.
When is next earnings date of Algorae Pharmaceuticals Ltd(LVCLY)?
The next earnings date of Algorae Pharmaceuticals Ltd(LVCLY) is .
Does Algorae Pharmaceuticals Ltd(LVCLY) pay dividends? If so, how much?
Algorae Pharmaceuticals Ltd(LVCLY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers